Andrew Maleki

Director of Finance/CFO at SURROZEN, INC.

Net worth: 19 533 $ as of 2026-09-29

37 year

Consumer Services

Health Technology

Profile

Andrew Maleki is Chief Financial Officer at Surrozen, Inc. since 2025.
Mr. Maleki was Head-Corporate Development at Lassen Therapeutics, Inc. from 2021 to 2025.
Mr. Maleki completed undergraduate studies at Yale University and earned an MBA from Harvard Business School.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
SURROZEN INC 0.01%	2026-06-14	607 ( 0.01% )	19 533 $	2026-09-29

Andrew Maleki active positions

Companies	Position	Start
SURROZEN, INC.	Director of Finance/CFO	2025-11-11

All active positions of Andrew Maleki

Former positions of Andrew Maleki

Companies	Position	End
Lassen Therapeutics 1, Inc. Lassen Therapeutics 1, Inc. BiotechnologyHealth Technology Develops novel and best-in-class biotherapeutics	Corporate Officer/Principal	2025-09-30

See the detail of Andrew Maleki's experience

Education of Andrew Maleki

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andrew Maleki's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Yale University Yale University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Harvard Business School Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Lassen Therapeutics 1, Inc. Lassen Therapeutics 1, Inc. BiotechnologyHealth Technology Develops novel and best-in-class biotherapeutics	Health Technology
Surrozen, Inc. Surrozen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing drug candidates	Health Technology